AbbVie in charts: Q1 Skyrizi, Rinvoq sales jump, while revenue from Humira continues to fall

AbbVie in charts: Q1 Skyrizi, Rinvoq sales jump, while revenue from Humira continues to fall

SeekingAlpha

Published